Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Intelligence-Mediated Discharge Document for Accessible Health Care (AIM-HEALTH): Protocol for a Prospective, Observational, Noninterventional Study.

JMIR research protocols·2026
Same author

Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia.

Haematologica·2026
Same author

Genetically driven immune microenvironment states associate with therapeutic responses in MYD88 mutant lymphomas.

Molecular cancer·2026
Same author

Evaluating the Impact of Fewer Frontline Intensive Chemotherapy Plus Venetoclax Consolidation Cycles on Outcomes in AML.

American journal of hematology·2026
Same author

NEAT1: a multifaceted long non-coding RNA in multiple myeloma.

Haematologica·2025
Same author

A tour of leukemia progress in 2025, viewed through the MD Anderson leukemia research lens.

Cancer·2025

Related Experiment Video

Updated: May 12, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

The bone marrow microenvironment in waldenstrom macroglobulinemia.

Irene M Ghobrial1, Patricia Maiso, Abdelkareem Azab

  • 1Dana-Farber Cancer Institute, Boston, MA, USA.

Therapeutic Advances in Hematology
|April 5, 2013
PubMed
Summary

Waldenstrom macroglobulinemia (WM) involves tumor cells homing to bone marrow niches for growth and survival. Targeting these interactions is crucial for future WM therapies.

Keywords:
Waldenstromadhesionbone marrowcell traffickinghomingmigrationniche

More Related Videos

Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies
08:51

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies

Published on: March 8, 2014

Related Experiment Videos

Last Updated: May 12, 2026

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia
06:33

Identifying Bone Marrow Microenvironmental Populations in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Published on: November 10, 2023

Bone Marrow-derived Macrophage Production
07:06

Bone Marrow-derived Macrophage Production

Published on: November 22, 2013

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies
08:51

A Three-dimensional Tissue Culture Model to Study Primary Human Bone Marrow and its Malignancies

Published on: March 8, 2014

Area of Science:

  • Hematology
  • Oncology
  • Cell Biology

Background:

  • Waldenstrom macroglobulinemia (WM) is a B-cell lymphoproliferative disorder.
  • WM tumor cells exhibit specific homing and growth within bone marrow niches.
  • These niches promote tumor cell survival and drug resistance.

Purpose of the Study:

  • To review the interaction between WM tumor cells and the bone marrow microenvironment.
  • To highlight the role of bone marrow stromal cells, endothelial cells, and mast cells in WM pathogenesis.
  • To discuss the implications for future therapeutic strategies.

Main Methods:

  • Literature review focusing on cellular interactions in WM.
  • Analysis of cell trafficking, adhesion, and signaling pathways.
  • Synthesis of current understanding of the WM tumor microenvironment.

Main Results:

  • WM tumor cells interact intimately with bone marrow stromal cells, endothelial cells, and mast cells.
  • Cellular migration, adhesion, and signaling pathways facilitate tumor cell trafficking and dissemination.
  • The bone marrow microenvironment is critical for WM cell growth, survival, and drug resistance.

Conclusions:

  • The bone marrow microenvironment plays a pivotal role in WM progression.
  • Therapeutic strategies must address both the tumor clone and its microenvironment.
  • Targeting the tumor-niche interaction offers a promising avenue for WM treatment.